Thomas Strüngmann
From Wikipedia, the free encyclopedia
Thomas Strüngmann (1950- ) founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. In February he and his brother sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion.
